ABSTRACT
The biochemical function of the plasma membrane calcium ATPases (PMCAs) is the extrusion of cytosolic Ca 2+ from the cell. Although this general function is well documented, the role of the complex isoform diversity and especially the contribution of specific isoforms to pathological conditions is less well understood. No human disease has been linked to a defect in any of the four PMCA genes. Nevertheless, isoforms do not have redundant functions, as shown by the indispensable role of PMCA2 demonstrated in transgenic mice. This review summarizes the results of recent analysis of the PMCA dysregulation in diseased cells or model systems of pathological conditions, including both acute disorders like hypoxia/ischemia and seizure, and slowly progressing dysfunctions like Alzheimer's disease, hypertension, diabetes and aging. Abnormalities in PMCA or its regulators have been described in various organs, reflected in changes of expression levels or in modifications or proteolysis of the PMCA protein.
Changes of PMCA function are often detected in cell types different from the specific type involved in the pathology, pointing to more general defects. Examples are erythrocytes in diabetes and blood platelets in hypertension. The changes suggest the significance of PMCA in Ca 2+ homeostasis both in excitable and nonexcitable cells.
INTRODUCTION
The recent extensive progress in the elucidation of the structure and function of Plasma Membrane Ca 2+ -transport ATPases (PMCA) has been summarized in several excellent reviews, including (1, 2). PMCAs form a subfamily of the P-type Ca 2+ -transport ATPases, that utilize the energy of the hydrolysis of ATP to drive uphill translocation of Ca 2+ across the membrane, transiently forming a phosphorylated intermediate during the transport cycle. The main structural property discriminating PMCAs from related subfamilies like the SERCAs of the internal Ca 2+ stores is the presence of an extended C-terminal tail forming an autoinhibitory domain and containing a calmodulin-binding site. Binding of Ca 2+ -calmodulin relieves the inhibition, providing a mechanism for regulation of PMCA activity by the cytosolic Ca 2+ concentration itself. PMCAs form the sole ATP-driven Ca 2+ -extrusion system of the plasma membrane. However, in most cell types they are assisted in their function by the Na + -Ca 2+ exchangers that catalyze the uphill extrusion of Ca 2+ at the expense of the energy delivered by the downward countertransport of Na + . Exceptions are erythrocytes of most mammalian species, and hair cells of the auditory and vestibular system that solely rely on PMCAs for Ca 2+ extrusion. In general, the Na + -Ca 2+ exchange system seems to have a higher transport capacity but a lower affinity for Ca 2+ .
PMCAs come in a great number of different isoforms. The reader is referred to recent reviews for a detailed survey (2). PMCAs are encoded by four genes, designated ATP2B1, ATP2B2, ATP2B3 and ATP2B4 in the human genomic database, encoding respectively PMCA1, PMCA2, PMCA3 and PMCA4. Alternative processing of the primary transcripts further increases the isoform diversity to at least twenty. This great diversity is a complicating factor in the study of the effect of pathophysiological conditions on the expression of PMCAs. Moreover, alternative processing of the PMCA mRNA occurs at sites that correspond to positions in the translated sequence that are crucial for regulation of the Ca 2+ pump activity, probably resulting in a great diversity at the functional level as well (1, 2). PMCA1 and PMCA4 are almost ubiquitously expressed and are thus considered as housekeeping isoforms. PMCA2 and PMCA3 show a cell-type specific expression. For some isoforms also a specific subcellular localization in polarized cells has been demonstrated.
Alternative splicing affects cytosolic domains. The rearrangement occurs at two sites, designated site C (close to the C-terminus and located in the calmodulinbinding domain) and site A, located in the domain between transmembrane segments 2 and 3. Site C affects the binding of calmodulin and the susceptibility to phosphorylation by protein kinase A and by protein kinase C. The C-termini of some isoforms contain a PDZ-binding domain. Site A affects the sensitivity of PMCA to the stimulatory effect of negatively charged phospholipids (3). Thus PMCA activity is able to respond in a cell-type specific and in a great variety of ways to changing physiological or pathological conditions.
Up till now no human disease has been linked to a defect in any of the PMCA genes. In mice, however, genetic defects in the gene encoding PMCA2 demonstrate that this isoform is indispensable for hearing and balanced movements. PMCA is expressed at high levels in the outer sensory hair cells of the organ of Corti. PMCA isoforms other than PMCA2 apparently cannot compensate for the loss of PMCA2 from these cells (4, 5, 6). In most cell types, however, non-genetic alterations of PMCA activity may be an important factor contributing to pathological conditions, considering the central role of PMCAs in the Ca 2+ extrusion pathway and the demonstrated involvement of Ca 2+ overload in the onset and progress of cellular dysfunction. In order to throw some light on the complexity of PMCA alterations in relation to disease, it is necessary to follow several distinct lines of investigation, each with its specific scientific questions and specific experimental approach. In the following overview we will make a distinction between studies at the organ level and at the cellular level, studies on changes in expression of PMCAs and on functional activity, experimental induction of gross alterations such as hypoxia/ischemia, and more specific modifications of the experimental conditions. Taken together, the findings indicate that changes in PMCA activity may contribute at least to the progress and the severity of several pathological conditions.
CONSEQUENCES OF LOSS OF FUNCTIONAL PMCA GENES
The lack of known human pathologies linked to defects in any of the four PMCA genes could be indicative of a high degree of redundancy of the functions of each of the gene products. However, the great isoform diversity is found in all vertebrates, and even the nematode Caenorhabditis elegans expresses three PMCA genes (7). Such conservation strongly suggests an evolutionary pressure to preserve this diversity because of the requirement of isoform-specific properties for optimal functioning of the cell and the organism. Because of the lack of specific PMCA inhibitors, further proof will require the study of genetically modified animals, or the technique of specific mRNA elimination (antisense or RNAi) on cultured cells or model organisms. The application of these strategies has already given some striking examples of the indispensability of specific PMCA gene products.
Transgenic PMCA2-deficient mice exhibit an unsteady gait, have difficulties in maintaining balance and have hearing defects. The Ca 2+ extrusion from hair bundles of sensory cells of the inner ear is catalyzed solely by PMCA pumps, the ionic composition of the endolymph being incompatible with Na + dependent Ca 2+ extrusion by the Na + -Ca 2+ exchanger. By immmunoanalysis, Crouch and Schulte (8) have documented the distribution of PMCA in the adult and developing gerbil cochlea. Remarkable changes occur in the expression pattern of different isoforms in the developing cochlea between PMCA1 and PMCA2 supporting the notion that PMCA isoforms perform specific and specialized functions (9). Immunohistological analysis has revealed that PMCA protein is also localized to the endolymph-secreting epithelial cells and participates in the regulation of the Ca 2+ concentration in the endolymph (10).
In general, PMCA2 exhibits a highly restricted tissue distribution, suggesting it serves more specialized physiological functions than some of the other isoforms. In line with the PMCA2 knockout experiments, three different spontaneous mutations in the PMCA2 gene have been identified, occurring in two variants of "deafwaddler" and one "wriggle mouse Sagami". Analysis of heterozygous deafwaddler mice mutants has shown that PMCA2 is important for the outer hair function mainly at high frequencies (11). Thus, the data strongly argue for a specific role of PMCA2 in the ear and against the general redundancy of the PMCAs (2). For a comprehensive overview the reader is referred to reviews by (9, 12, 13).
ALTERATIONS OF PMCA PROTEIN EXPRESSION LEVELS
The proper cellular response to external and internal signals includes changes in the expression level of molecular components of different Ca 2+ -regulatory pathways. PMCA isoform expression and their alterations in pathological conditions due to interactions on the transcriptional level have only recently begun to be elucidated. Changes in the mRNA levels as well as in alternative mRNA processing have been described in response to a variety of factors, among them Ca 2+ itself, vitamin D and steroids. In addition to their well known transcriptional effects, steroids have also been shown to have short-term effects on PMCA function. This section is restricted to changes observed in well controlled experimental conditions. Many other cases of altered expression levels will be described in later sections on pathological situations or disease-related conditions. The cause of these changes is often not well established.
Role of PMCA in growth and differentiation 4.1.1. Neuronal cells
Calcium metabolism undergoes considerable changes during cellular differentiation. In neurons, differentiation induces up-regulation of calcium channels which help in the triggering of Ca 2+ -dependent events (14) . More recent evidence shows that also the PMCA expression is increased in parallel, probably reflecting the greater demand for Ca 2+ extrusion. Experiments have been conducted in vivo and on neuronal cells in culture, particularly cerebellar granule cells, PC-12 or the derived PC-6 cells and neuroblastoma cell lines.
PMCA2 and PMCA3 are neuron-specific isoforms. During neuronal differentiation, up-regulation of these isoforms appears to be a general phenomenon, irrespective of the in vivo or in vitro situation, or of the differentiation-inducing stimulus, as will be shown below. Changes of PMCA1 and PMCA4 are less pronounced and more variable. Although it is difficult to prove a causal link between PMCA activity and differentiation, additional experiments involving manipulation of PMCA activity, including work on nonneuronal cells, may suggest such a connection.
PMCA2, PMCA3 and to a lesser extent PMCA4 are up-regulated during the development of the cerebellum (15) . Similarly, rat cerebellar granule cells in culture up-regulate PMCA activity when they are induced to differentiate, either by chronic exposure to K + -depolarizing solution or to NMDA receptor agonists, treatments that both cause a sustained increase of [Ca 2+ ] i . PMCA2 and PMCA3 are strongly up-regulated whereas a brain-specific splice variant of PMCA4, PMCA4CII, is down-regulated (15) . Because this isoform contains a PDZ-binding domain, its specific loss may reflect a requirement for removal of PMCA activity at specific sites in differentiated cells. Guerini et al. (16) In addition to its effect on PMCA gene expression, elevation of [Ca2+]i also affects the splicing pattern of the mRNA. In the neuroblastoma cell line IMR-32, depolarization results in an up-regulation of PMCA2 and in a change of its N-terminal splicing pattern (20).
Endothelial cells and smooth-muscle cells
In endothelial cells, the PMCA1 gene is upregulated by agonist-and tissue-specific signalling pathways. Protein kinase A and protein kinase C have been implicated in the increase of PMCA1 expression. The regulation of this response is dependent on transcriptional activation of the PMCA1 gene via a core segment of the gene promoter (-442 to + 169) (21).
Interestingly, the PMCA1 promoter has recently been demonstrated to possess two binding sites for the transcription factor c-myb. Binding of c-myb represses transcription of PMCA1 in vascular smooth muscle cells at the G 1 /S cell cycle interface (22). C-myb is a transcription factor vitally important for the control of cell proliferation in conditions such as atherosclerosis and restenosis and it is also involved in the regulation of apoptosis by modulation of [Ca 2+ ] i . The reduction in cmyb activity inhibits cell cycle progression and decreases intracellular Ca 2+ concentrations. The effects are largely mediated by an increased rate of Ca 2+ extrusion, which is associated with increased levels of PMCA1 mRNA and protein, in parallel with lower but similar changes of PMCA4 mRNA. Conversely, overexpression of PMCA1 resulted in reductions of [Ca] i , G 1 to S transition and rate of cell proliferation (23).
Muscle cells
Overexpression of PMCA4 in the myogenic cell line L6 accelerates differentiation (24). This effect is in line with the anti-proliferative effect described above for vascular smooth cells. In contrast, overexpression of PMCA in the heart of transgenic mice stimulates growth of isolated cardiac cells in response to fetal calf serum or adrenergic agonists and attenuates induction of gene expression in response to endothelin 1 (25, 26).
Ca
2+ transporting epithelia Vitamin D-dependent Ca 2+ transporting tissues express PMCA1b as the major isoform. Pannabecker et al. (27) first showed that 1,25(OH) 2 vitamin D 3 upregulates the plasma membrane Ca 2+ -pump protein in the intestine. Because nuclear PMCA mRNA was increased, the authors attribute the effect to an increased rate of transcription. Recently, however, it has been shown that post-transcriptional effects contribute to the up-regulation of PMCA1 (see 4.2) and that any positive regulatory vitamin D response element must lie outside the core promoter (28).
Taken together, all these results suggest that the function of PMCAs is not restricted to simple prevention of calcium overload, but may be extended to an active involvement in the fine tuning of [Ca 2+ ] i with potentially important consequences for cellular functions such as growth (18).
Effects of steroids
The brain is a site of extensive synthesis and metabolism of steroid hormones such that the accumulation of steroids appears to be, at least in part, independent of adrenal or gonadal sources.
Low levels of corticosteroids, mainly glucocorticoids, are important factors for learning and memory due to their genomic actions in the hippocampus. Chronically high levels of corticoids have profound effect on hippocampal structure and function and can even result in irreversible neurodegeneration. In a screen for genes repressed by high doses of glucocorticoids in rat hippocampus, the PMCA1 message has been picked up (29). Confirming this result, repression of PMCA1 by corticosterone was also observed in cultured hippocampal neurons, but only when the cells were in the differentiated state.
Because corticosteroids are mediators in the response to stress, Bhargava et al. (29) also investigated the effect of stress on PMCA1 expression. These effects were more complex, suggesting that corticosteroids are only one pathway in the PMCA response to stress. In intact animals cold stress itself repressed expression of PMCA1 in the hippocampus, whereas PMCA1 in other brain regions did not change. In adrenalectomized animals, cold stress even increased hippocampal PMCA1 expression. Defects in the balance between glucocorticoid-mediated and non-glucocorticoidmediated effects on PMCA1 expression may have adverse effects on neuronal function and ultimately result in irreversible neuronal damage (29).
The PMCA-glucocorticoid relation is confirmed by the converse experiment already described above (see 4.1.1.), demonstrating that the loss of PMCA1 by using antisense technology in PC-6 cells is associated with increased glucocorticoid receptor transactivation (18). Several neuroactive steroids have been shown to affect the activity of plasma membrane Ca 2+ -stimulated ATPase activity independent of transcriptional effects. In dog synaptosomes, testosterone stimulated the activity whereas progesterone had an opposite effect. In rat brain neuronal membrane preparations or purified rat Ca 2+ -ATPase, an increase of the activity of Ca 2+ -ATPase was demonstrated after a short-time incubation with physiologically relevant concentrations of pregnenolone, estradiol, testosterone and dehydroepiandrostendione, which suggests that local steroid synthesis could allow permanent Ca 2+ -independent non-genomic Ca 2+ -ATPase regulation (30).
MODIFICATIONS OF PMCA PROTEINS
It is generally accepted that oxidative stress, initiated mainly by reactive oxygen/nitrogen species [RO(N)S], contributes as a pathogenic factor to several pathologies including ischemia/reperfusion injury (IRI), and inflammatory and degenerative diseases. The disruptive action of RO(N)S involves membrane lipid peroxidation, membrane protein modification, DNA damage and formation of advanced glycosylation products. Each of these events may cause alterations of membrane structure and function, including membrane fluidity and activity of structural proteins. The changes of redox balance often lead to activation or silencing of genes encoding transcription factors such as AP-1 and NF-κB, antioxidant defense enzymes, and structural proteins which may modulate signal transduction cascades and redirect gene expression in eukaryotic cells (31).
Functional modifications of PMCA induced by oxidative stress
The effect of oxidative stress on membranes is known to involve modifications of both protein and lipid. Because the activity of the plasmalemmal Ca 2+ -transport ATPase not only depends on the integrity of the pump protein itself but also on the lipid composition of the membrane, it is often difficult to find the exact mechanism responsible for oxidative impairment of Ca 2+ pump activity. Evidence for both types of mechanisms has been obtained, depending on the oxidative agent and on the cell type.
The first indications of PMCA protein as a possible target of free radicals came from studies on erythrocytes which showed that incubation of red blood cells in the presence of non-heme iron, ferrous sulfate and EDTA, or t-butyl hydroxyperoxide resulted in a concentration-and time-dependent inhibition of PMCA (32 -34). The inhibition was associated with crosslinking of membrane proteins. Free-radical scavengers prevented both PMCA inhibition and protein crosslinking.
Clear evidence for a direct effect on the Ca 2+ pump protein itself has been obtained for Ca 2+ transport inhibition in erythrocytes by activated neutrophils (35). The inhibition is caused by superoxide produced by neutrophils which is converted to other radicals by a Fenton-type reaction. By using an antibody to the Ca 2+ pump protein, it was shown that the inhibition was accompanied by protein fragmentation. A contribution of lipid peroxidation was unlikely. Pump protein degradation has also been demonstrated during exposure of erythrocytes to peroxynitrite (36).
A direct inhibitory efffect on the erythrocyte Ca 2+ -transport ATPase is also seen with 4-OH-2,3-trans-nonenal (HNE), an aldehyde product of fatty acid oxidation, although this effect is accompanied by an increased passive Ca 2+ permeability, indicating an effect on lipids as well. The inhibition of the Ca 2+ pump is due to the depression of the basal as well as the calmodulinstimulated activity (37). Pretreatment of calmodulin itself with HNE did not impair its ability to stimulate the Ca 2+ -ATPase activity. Detailed analysis of the kinetics of Ca 2+ pump inhibition demonstrated a reduction of V max as a result of a direct effect on the enzyme, probably by irreversible modification of functionally important sites on the enzyme molecule (38). The effect of HNE provides an example of the complexity of oxidative damage due to additional mechanisms that may be involved. It has been shown that HNE is present in oxidized low density lipoproteins (LDL), which are found in atherosclerotic lesions (39). Thus, together with the modification of low density lipoproteins (LDL), the Ca 2+ pump and other proteins need to be considered as additional sites of action of HNE in atherogenesis or other radical-generated pathologies. 2+ stores are necessary for seizureinduced cell death. The potential participation of PMCAs has been analyzed by studying the changing expression pattern in rat hippocampus during kainateinduced seizures (72). Relative mRNA levels for three PMCA isoforms (PMCA 1, 2 and 3) were examined by in situ hybridization. PMCA1 and PMCA2 were decreased in pyramidal cells of the CA1 and CA3 regions 12 hours following kainate injection. In some pyramidal cells, PMCA1 remained significantly below control levels for 72 hours post-injection. Decreased PMCA expression preceded the onset of neuronal loss. The distinct time course of the changes in PMCA1 and PMCA2 mRNAs and the lack of effect of kainate on PMCA3 expression suggests that early decreases in mRNAs can not simply be explained by cell death of pyramidal neurons. Interestingly, expression of PMCA2 showed a clear decrease in the granule cells of the dentate gyrus already 4 hours after injection. However, its expression quickly returned to control levels after 24 hours. It could be hypothesized that this observation is related to the fact that granule cells of the dentate gyrus are more resistant to excitotoxic and ischemic cell death (31, 73). Thus, the PMCA recovery seems to maintain [Ca 2+ ] i at levels more close to physiological during times that are crucial for cell survival.
In humans, the hippocampus expresses relatively high levels of PMCA2 and PMCA4 mRNAs. It could be speculated that the increased PMCA expression may contribute to the higher resistance of this region to excitotoxic injury.
A significant depression of Ca 2+ -ATPase activity has also been observed on rat brain cortex following pentylentetrazol-induced status epileptic seizure and streptozotocin-induced diabetes (74). The observed decrease in Ca 2+ -ATPase activity can reflect the diminution of the total number of PMCA protein molecules due to decreased translation or due to the decreased number of total cells, or could be due to a decreased number of active enzyme entities caused by fragmentation, aggregation or chemical alterations (49). The reduction of Ca 2+ -ATPase activity following treatments inducing status epilepticus or diabetes may thus be interpreted as one of the initial biochemical lesions which start a cascade of processes which may later culminate in cell death.
Stroke and atherosclerosis in humans significantly affect erythrocyte membrane lipid composition and ATPase activities. Measurements on 51 patients with acute cerebral infarction and 12 patients with atherosclerosis revealed a decreased erythrocyte deformability, an increase in the membrane cholesterol/phospholipid ratio and a decrease of Ca 2+ -ATPase and Na + -K + -ATPase activities. It is interesting that changes exist before the occurrence of stroke and could thus serve as an early indication of the patient's state in clinical settings (75).
PMCA alterations in Alzheimer`s disease (AD)
The physical properties of cell membranes and calcium homeostasis in both the central and peripheral nervous system are changed in Alzheimer's disease. The amyloid beta-peptide (Abeta) that accumulates in the brain in AD is potentially neurotoxic. As shown by experiments on cultured hippocampal neurons, addition of Abeta causes loss of Ca 2+ homeostasis and neuronal injury which is preceded by impairment of the Na + -K + -ATPase activity (48). Although the authors consider the inhibition of Na + -K + -ATPase activity as the main cause of the disruption of Ca 2+ regulation, they also observe a reduction of Ca 2+ -ATPase on exposure of synaptosomes prepared from postmortem human hippocampus to Abeta. Antioxidants such as vitamin E and propylgallate significantly protected cells against the ATPase impairments and neurotoxicity, suggesting a role for reactive oxygen (nitrogen species) in the pathogenesis caused by Abeta (48). A recombinant carboxy terminal 105 amino acid fragment of beta-amyloid precursor protein containing the full length of Abeta (CT 105) has in vitro a more potent effect than that of Abeta on cultured neuronal Ca 2+ uptake and Na + -Ca 2+ exchanger (76). In addition, CT 105 disrupts calcium homeostasis and renders neuronal cells more vulnerable to glutamate-induced excitotoxicity in rat primary cortical neurons and PC 12 cells (77). It was not shown, however, that the effect directly involves PMCA activity.
Increased exposure to aluminium has been considered as one of the causative factors of AD. Mundy et al. (78) studied the effect of aluminium on the activities of Ca 2+ transport in microsomes and synaptosomes isolated from adult rat frontal cortex and cerebellum. In all organelles addition of 50-800 µM AlCl 3 resulted in a concentration-dependent inhibition of Ca 2+ transport. However, the same concentrations induced an activation of Ca 2+ -dependent ATPase activities from both brain regions. The authors proposed that aluminium acts at multiple sites of neurons to displace both Ca 2+ and Mg 2+ thereby increasing the ATPase activity but disrupting transport of Ca 2+ . It has, however, not been proven that any of these effects involve PMCA activity rather than organellar Ca 2+ pumps.
The hypothesis that abnormalities in cellular Ca 2+ regulation might be involved in the etiology of AD was further supported by experiments on fibroblasts from AD patients (79). The Mg 2+ -dependent, Ca 2+ -stimulated ATPase presented an approximately two fold higher K m value in Alzheimer fibroblasts than in controls. Although the authors ascribe this difference to an effect on PMCA, this interpretation awaits further proof because the experiments were performed on crude homogenates.
Structural and functional alterations of PMCA in brain hypoxia/ischemia
Although the Ca 2+ -dependent processes seem to play a major role in cell damage, the timing of Ca 2+ -dependent damage and the role of increased ability to buffer or reduce cytoplasmic Ca 2+ loads in ischemic tolerance are still unresolved. Ischemic death of specific neurons shares some of the mechanisms of classical forms of apoptosis and necrosis. Studies on lower mammals have suggested that neuronal death after brief ischemia in the CA1 hippocampal region occurs by apoptosis. However, studies on monkeys and humans rather support necrosis, the calpain-cathepsin dependent cell degeneration, as the primary mechanism (80).
In Jurkat cells and neuroblastoma cells undergoing apoptosis, only IP 3 receptor type 1 has recently been shown as a caspase 3 substrate among the proteins associated with Ca 2+ transport (81, 82). Digestion of IP 3 receptors may interfere with Ca 2+ -signaling pathways and intracellular Ca 2+ homeostasis. These results provide an explanation for the lower levels of this protein in AD and other neurodegenerative diseases (82).
On the other hand, ion transport systems may also be decisive to cell death. It has been recently shown by (83) that caspases can cleave different plasma membrane Ca 2+ pump isoforms and thereby cause membrane lysis in cells undergoing apoptosis.
In recent work from our own laboratory we have attempted to investigate the potential role of PMCAs in altered Ca 2+ homeostasis following transient global ischemia and prolonged reperfusion. Isoform-specific antibodies against three human isoforms of PMCA but recognizing the corresponding protein in the rat raised by Stauffer (84, 85) were used for immuno-localization of PMCAs in the different regions of gerbil brain. Similarly to human and rat tissues, all three gene products (PMCA1, 2 and 3) were detected in the hippocampus, frontal cerebral cortex and cerebellum. PMCA1 was expressed in the highest quantity in the cortex and hippocampus. The PMCA2 signal was generally lower than that of PMCA1 and was highest in the cerebellum, with a moderate amount in the cortex. Anti-PMCA3 antibody stained weakly and was localized in the cerebellum and in the hippocampus. As expected from our previous results using non-isoform discriminating antibodies (86), 10 min global forebrain ischemia had no effect on the level of any PMCA isoforms. However, ischemia followed by reperfusion led after up to 7 to 10 days to a significant decrease of the PMCA immuno-signal in the forebrain membranes. This decrease could be ascribed solely to the selective loss of PMCA1 signal (to 59 and 63 % of control levels) and the major loss was localized to the hippocampus, which is thought to be the most affected brain region (CA1 sector) after global ischemia. PMCA2 and PMCA3 did not show significant differences after IRI neither in the hippocampus nor in the cerebral cortex. Combined with the observation that the tubulin level does not differ significantly between control and ischemic tissue, these data demonstrate that the decrease of PMCA1 can not simply be explained by cell death or a general response of all isoforms to ischemia/reperfusion injury (87). We don't know yet whether the major effect on PMCA1 level occurs at the stage of transcription, translation or degradation.
A possible explanation arises from the experiments of Neumar´s group (88, 89). Transient ischemia in rats induced by bilateral carotid occlusion and hypovolemic hypotension followed by 48 hours reperfusion induced proteolytic fragmentation of PMCA protein in parallel with a considerable depression of Ca 2+ -ATPase activity to 51 per cent prior to morphological evidence of neuronal degeneration. Proteolysis in the hippocampus was caused by increased calpain activity. However, the antibodies used in this study (5F10) did not discriminate between individual isoforms and thus direct evidence concerning the selective loss of PMCA1 in gerbil hippocampus is still lacking. Whether PMCA1 is more than other isoforms vulnerable to excitotoxic injury or to action of free radicals (protein degradation is under redox control) (55), in ischemia is not yet known. However its selective decrease in the most affected area suggests a specific role in the dynamic regulation of [Ca 2+ ] i and in the derangement of Ca 2+ homeostasis leading to the delayed death of hippocampal neurons. It should be remarked that in parallel with the decrease of PMCA a number of other Ca 2+ transport proteins are affected during the reperfusion period: the intracellular Ca 2+ pump (90, 91) and the IP 3 receptor (92).
Although a similar progressive reduction of histochemically determined Ca 2+ -ATPase activity has been documented in gerbil CA1 hippocampal neurons during reperfusion period (93), the results are less indicative due to the unspecificity of the histochemical determination. However, severe disturbances of the Ca 2+ -ATPase precede the early stages of delayed neuronal death and thus seem to occur far earlier than the morphological degenerative changes or increased calcium content in the CA1 pyramidal cells.
Interestingly, the ubiquitin/proteasome pathway is thought to play an important role in cachexia, characterized by profound tissue wasting, that frequently complicates malignancies. The status of the Ca 2+ -dependent proteolytic system has been evaluated in the gastrocnemius muscle of AH-130 tumor bearing rats by measurement of the activity of calpain, of calpastatin, its natural inhibitor, and of the PMCA protein, a calpain substrate. After tumor transplantation, a decrease in PMCA Ca 2+ -ATPase was the prominent feature, while the level of the SERCA pump did not change. The diminution of PMCA protein is caused by the progressively increasing dysbalance in the calpain/calpastatin ratio since the level of total calpastatin activity progressively declined, while total calpain activity remained unchanged. Moreover, decreased levels of both calpastatin and plasma membrane Ca 2+ -ATPase have also been detected in the heart of the tumor-bearers, which strongly suggests a more general Ca 2+ -dependent proteolysis which may play a role in the muscle protein hypercatabolic response (94).
A clinically very interesting situation is the pretreatment by non-lethal ischemic loading in CA1 hippocampal neurons (95), which is thought to cause protection against Ca 2+ toxicity (ischemic tolerance). As shown in ischemia-tolerant gerbils, the level of Ca 2+ -ATPase determined by histochemical methodology in CA1 neurons exposed to a non-lethal 2 min ischemia, increased significantly before the start of the 5 min of lethal ischemia and even remained at a higher level subsequently, compared to ischemia non-tolerant CA1 neurons. This result strongly resembles data on CA3 neurons, which are constitutively resistant to such periods of ischemia (96). However, due to the methodology used in Ca 2+ -ATPase analysis and because of a parallel enhanced mitochondrial Ca 2+ buffering system in tolerant regions, the role of Ca 2+ -ATPase in the process of acquired tolerance to subsequent ischemia might be questioned.
In fact, we recently showed that the extent of lipid and protein modifications in a whole rat neuronal preparation induced by IRI occurs mainly during the period of reperfusion. Similarly, an increase of immunoreactivity for HNE-modified proteins in CA1 hippocampal region was seen in the reperfusion period after transient ischemia in gerbils. Loss of immunoreactivity increase in ischemic tolerant animals points to the important role of HNE in oxidative stressinduced altered neuronal signalling and survival of neurons (54).
Chronic cerebral vasospasm as a consequence of subarachnoid hemorrhage (SAH) has also been shown to be associated with impaired Ca 2+ regulation in smoothmuscles of cerebral arteries (97). Experimental SAH in the canine basilar artery caused a decrease of the activity of plasma membrane Ca 2+ -ATPase as a result of single or double experimental blood injection. Concomitantly there was an increase of the plasma membrane permeability to Ca 2+ . The harmful substances in the extravasated blood and other factors such as superoxide which are released from the oxyhemoglobin in a subarachnoid clot might be causative agents in the early occurrence and long lasting decrease in Ca 2+ -ATPase in experimental SAH.
Role of PMCA in myocardial pathologies
In concentration had a protective effect on the ischemiainduced alterations of the calmodulin-stimulated Ca 2+ -ATPase activity. The authors propose that the decrease of Ca 2+ -ATPase activity after ischemia is caused by alterations of the calmodulin-binding site of the enzyme.
An insensitivity of PMCA activity to ischemia was found by (105). In sarcolemmal vesicles from rabbit heart, the initial velocity of ATP-dependent Ca 2+ transport was unaffected even by 2 hours of ischemia, whereas the Na + -Ca 2+ -exchange activity was significantly inhibited and the number of Ca 2+ channels was reduced. The maintenance of normal function of the ATP-dependent Ca 2+ pump indicates that there is not simply a gross disruption of all sarcolemmal function during ischemia in this model.
Oxidative stress may play a crucial role in cardiac dysfunction, including ischemia/reperfusion injury (for review, see 106). Dhalla and coworkers have investigated the effect of oxidative stress on PMCA function in a series of studies, both on perfused hearts and directly on isolated sarcolemmal membranes. Depression of sarcolemmal PMCA activity similar to that in ischemia/reperfusion was observed by cardiac perfusion with radical-generating solutions. In ischemia as well as with radical-generating perfusion, scavenging enzymes prevented the effects. The ATP-dependent Ca 2+ transport of purified membranes from control hearts was inhibited by oxygen radicals, and also this effect was reversed by antioxidant enzymes (98, 107). Similar effects have also been observed on coronary artery smooth-muscle cells (108). ROS possibly in the form of hydrogen peroxide generated by the metabolism of alloxan inhibit Ca 2+ transport by plasma membranes isolated from dog aorta. This action may contribute to the vasoconstrictive side effect of this drug (111).
The role of oxidative stress may not be restricted to ischemia/reperfusion-related dysfunction. Oxidative damage may also be an important factor in cardiomyopathy caused by excessive amounts of circulating catecholamines. Experimental treatment of rats with a high dose of the synthetic catecholamine isoproterenol resulted, in addition to morphological and functional changes, in an increased level of oxidative stress products such as malondialdehyde content, conjugated dienes and low glutathione redox ratio. 
The cellular dysfunction that eventually leads to multiple organ failure in sepsis is unclear. Sepsis is characterized by impaired hepatic glucose homeostasis and muscle protein metabolism, all processes that involve Ca 2+ . As shown by (120), the impairment of the capacity to extrude Ca 2+ from erythrocytes as well as from liver plasma membranes appears to have a general pathophysiological significance in the development of severe sepsis. The degree of inhibition of the Ca 2+ pump depends on the severity of the septic process, indicating that Ca 2+ pump activity represents a potentially useful marker for general cellular dysfunction to evaluate the clinical manifestations of sepsis.
Functional alterations of PMCA in diabetes
The Ca 2+ ion is deeply involved in the regulation of insulin secretion. Secretagogues induce a significant increase of [ (136) and (137) who demonstrated that in vitro glycation of the Ca 2+ pump diminishes Ca 2+ -ATPase activity by up to 50%. This decrease was explained by the reaction of glucose with one essential Lys residue probably located in the vicinity of the catalytic site. The higher glucose concentration inhibits in a time-dependent manner the activity of purified Ca 2+ -ATPase reactivated by defined phospholipids, suggesting a direct glycation of the enzyme (137) . This interpretation has been questioned, however, by more recent findings. Normal human red blood cells exposed to high glucose concentrations (30 -100 mM) for 6 hours in vitro did not exhibit any effect on V max of PMCA. Also the mean V max from diabetic subjects was not significantly different from that of controls. Results on experimental diabetes induced by streptozotocin in rats were in the same line. These studies question the previous findings and support the notion that a high glucose concentration in plasma is not a causative factor for the altered ability of red blood cells to extrude Ca 2+ (138) .
Lipoic acid lowered lipid peroxidation and protein glycosylation, and increased Na + -K + -and Ca 2+ -ATPase activities in high-glucose exposed red blood cells. This effect could be the mechanism by which lipoic acid may delay or inhibit the development of neuropathy in diabetes and may form the basis of a new therapeutic approach (139) .
Lymphocytes are also affected by diabetes. Basal [Ca 2+ ] i is elevated in diabetic type 2 subjects and is positively correlated with the glucose and hemoglobin A1c level. In addition, a significant reduction of PMCA Ca 2+ -ATPase activity was detected in diabetic subjects compared to controls which suggests that Ca 2+ accumulation in the cell is at least partially caused by depression of PMCA activity (140) .
In renal cortical cells, Levy and Gavin (141) have shown not only a diabetes-induced decrease of plasma membrane Ca 2+ -ATPase activity but also a direct regulation of this activity by phosphorylation of the enzyme induced by insulin. They further demonstrated in genetically obese rats that loss of insulin regulation of ATPase activity may impair insulin effects and therefore contribute to insulin resistance. Contrary to this report, Evcimen et al. (142) observed an elevation in Ca 2+ -ATPase activity on whole kidney in streptozotocininduced diabetes. This increase may have been caused by higher Ca 2+ levels in diabetic kidneys resulting from a compensatory response of the enzyme to high levels of the ion.
Brain synaptic PMCA activity is inhibited by chronic hyperglycemia. The inhibition is also associated with a significant reduction of the minimum effective dose for inhalation anesthetics in experimental animals (143) . Because inhalation anesthetics themselves also cause an inhibition of PMCA activity, the authors suggest that in specific brain regions PMCA could play an important role in inhalation anesthesia. Oner et al.
(74) confirmed the diabetes-induced decrease of brain Ca 2+ -ATPase activity and in addition observed such an effect as a consequence of experimentally induced seizures.
Oxidized low density lipoproteins (LDL) probably play a pathogenic role in diabetes-induced and non-diabetes-induced atherosclerosis by damaging both endothelial barriers and blood-cell membranes. In platelets, oxidized LDL but not native LDL (in concentrations considerably below the level of circulating LDL) increases the cytoplasmic Ca 2+ content and inhibits the activity of the Ca 2+ -ATPase of the plasma membrane. Since no change in membrane fluidity was observed in platelets exposed to oxidized LDL, a direct inhibition of PMCA protein has been proposed. In clinical settings such as diabetes and hypertension, altered Ca 2+ -ATPase activity in platelets might contribute to the increase of [Ca 2+ ] i (40). LDL from normolipidemic insulin-dependent diabetic patients significantly increased the in vitro platelet aggregation response to ADP compared with platelets incubated with control LDL (144) . An altered interaction between circulating lipoproteins and platelets is thus suggested as a new mechanism of the early development of atherosclerosis in diabetic patients.
In contrast to the changes induced in most other tissues, the ATP-dependent Ca 2+ uptake and Ca 2+ -ATPase activity in sarcolemmal fractions from skeletal muscle appear to be increased in diabetic animals (145) . These changes were apparent three or four weeks after streptozotocin administration. Treatment of diabetic animals with insulin for 14 days reversed the changes in Ca 2+ transport activities toward the control levels. On the other hand, sarcolemmal Mg 2+ -ATPase and Na + -K + -ATPase activities remained unchanged and no difference in the sarcolemmal phospholipid composition and protein electrophoretic pattern was evident between the control and experimental groups. The higher activity of the sarcolemmal Ca 2+ transport is probably associated with hyperfunction of skeletal muscle in diabetic rats. However, it appears that in cardiac muscle, like in most cell types, the sarcolemmal Ca 2+ pump is defective in diabetic myocytes (146) .
Abnormalities of PMCA in erythrocyte-related pathologies
Abnormalities of the Ca 2+ pump of erythrocytes, possibly reflecting systemic alterations of the pump in other tissues as well, have been described in several disease conditions (147) .
In sickle cell anemia, circulating red blood cells are heterogeneous in age, morphology, volume, membrane structure and ion transport. Much of this heterogeneity is the result of the polymerization of hemoglobin which leads to secondary abnormalities of cell ion and water content. Sickle red cells (SS cells) have an abnormally high total Ca 2+ content which increases with reticulocyte maturation.
The oxidation of hemoglobin to methemoglobin and its degradation leads to the accumulation of hemin and free iron in the red blood cells. The Ca 2+ -ATPase activity of erythrocytes has been shown to be inhibited by different types of hemolytic amenia such as sickle cell disease or glucose-6-phosphate dehydrogenase deficiency. Leclerc et al. (33) have shown that the erythrocyte Ca 2+ -ATPase activity is inhibited by hemin, the ferric protoporphyrin IX (FP) complex. Because the inhibition of the enzyme was partially restored by the reducing agent dithiotreitol, it was concluded that hemin induces the oxidation of thiol groups of the protein. The next Leclerc study (148) demonstrated that non-heme iron also inhibits the calmodulin stimulation of the Ca 2+ -ATPase activity. In contrast with hemin, the non-heme iron inhibition is prevented by butylated hydroxytoluen, a protective agent of lipoperoxidation, and dithiotreitol does not restore the enzyme activity. Erythrocyte membranes in protein-energy malnutrition (kwashiorkor-KWA) which is clinically linked with anemia contain a detectable amount of nonheme iron which causes lipid peroxidation and impairment of membrane functions. In addition, isolated KWA membranes are more susceptible to oxidative stress which is expressed in a lower affinity of the Ca 2+ -ATPase for ATP and calmodulin. The excessive generation of ROS and the higher sensitivity of the membranes to oxidative stress may be responsible for the altered red blood cell Ca 2+ homeostasis in this pathology (153) .
Tarui´s disease is another pathology with increased Ca 2+ content of erythrocytes. Due to the enhanced erythrocyte Ca 2+ permeability in all patients, compensatory mechanisms such as increased Ca 2+ pump activity are proposed to be initiated (154) .
Clinically very interesting is the toxic effect of chronic exposure to low lead concentrations in the environment. Human patients with lead toxicity develop hematological, gastrointestinal and neurological dysfunction. In 247 mothers and their newborns, maternal and cord blood has been sampled at delivery. Erythrocyte Ca 2+ -ATPase activity was correlated with the lead content in the blood. The results have shown that the level of lead in maternal and cord blood and mothers' hair was negatively correlated with the red blood cell Ca 2+ -ATPase activity, suggesting that lead toxicity can at least in part be explained by the inhibition of the red blood cell Ca 2+ -ATPase (155).
An abnormal red-cell Ca 2+ pump has also been found in idiopathic hypercalciuria, a common disorder with possible enzyme abnormalities in Ca 2+ transport. Erythrocytes in patients with hypercalciuria and history of calcium oxalate kidney stones expressed an increased Ca 2+ -ATPase activity compared to healthy controls. Interestingly, urinary calcium excretion correlated well with the Ca 2+ -ATPase activity, suggesting a relation between Ca 2+ -ATPase activity and hypercalciuria (156) . However, in a more recent study (157) , a group of twenty-four children with idiopathic hypercalciuria did not show any changes in the abundance of erythrocyte PMCA protein or in Ca 2+ -ATPase activity compared to control children.
Friedrichs and Wurz (158) have pointed to an interesting aspect of the erythrocytes of children patients. The calmodulin-stimulated red-cell Ca 2+ -pump activity was higher in females than in males. There were no differences in basal ATPase activity. The basal activity of PMCA in children up to the age of 7 years was higher than that of adults. A distinct increase in activation by calmodulin was observed with a maximum at the age range of 8-13 years. These data should be taken into account for the setting of normal values of the population.
An alteration in the Ca 2+ pump in red blood cells (higher V max , lower K m ) has been described in patients with Duchenne muscular dystrophy (159) . The change was specific for Duchenne dystrophy because it did not occur in other forms of dystrophy.
In patients with bipolar illness there is a much greater scatter in the Ca 2+ dependence and calmodulin sensitivity of the Ca 2+ pump than in normal subjects (160). Meltzer et al. (161) reported that the activity of erythrocyte calmodulin-stimulated Ca 2+ -ATPase is higher in lithium-treated bipolar subjects than in normal controls, or than in bipolar subjects treated with psychotropic medications without lithium. This difference was due an increase of the number of Ca 2+ pumps.
Analysis of Ca
2+ -ATPase activity of red-cell membranes from patients with cystic fibrosis revealed a reduced activity (162) . A lower V max of ATP hydrolysis was also observed by (163) . However, it can be questioned whether these effects occur specifically on the PMCA pump because of the general disturbance of the membrane lipid environment in this pathology. entry pathways and are used in the treatment of peripheral vascular disorders seen in elderly people and several pathologies. Pentoxyphilline (0.5 -5 mM), a dimethylxanthine, added directly to the assay medium activates the Ca 2+ -ATPase of inside-out red-blood cell vesicles of young and old patients. However the activation was age-related with the greater percentage of activation in vesicles from erythrocytes of older patients. Pentoxyphilline also affected Ca 2+ uptake activity. The early burst of Ca 2+ uptake decreased in the vesicles from young but not from older erythrocytes (165).
Plasma membrane Ca

2+ pump in kidney disorders
In the mammalian nephron, 95 percent or more of the Ca 2+ filtered in glomeruli is reabsorbed in tubular segments. Although a substantial portion of the tubular reabsorption, especially in the proximal part, is a passive process, there is a considerable contribution of PMCA pumps to the overall absorption. The Ca 2+ -ATPase activity overlaps with the cellular localization of mRNAs encoding PMCA proteins. PMCA1 is a house-keeping form, mostly present in non-epithelial interstitial cells of glomeruli. PMCA2 is detected in epithelial cells of cortical tubules. PMCA3 is located mainly in the outer medulla (166) and thin descending loop of Henle (167) . PMCA4 is present in the outer medullary zone. In kidney tubular cells, as in intestinal epithelia, calcitriol and vitamin D 3 upregulate the expression and the activity of the 1b isoform of the plasma membrane Ca 2+ pump (168) . In MDCK (MadinDarby canine kidney) cells, a model of distal tubular cells, it has recently been shown for the first time that Ca 2+ inhibits its own transcellular transport. This inhibition is mediated by a Ca 2+ -sensing receptor which inhibits in a concentration-dependent manner PMCA activity, via phospholipase C-dependent pathways (169) .
The expression of PMCA isoforms can be selectively modulated by pathophysiological stimuli. Unlike the constant expression level of PMCA1 and PMCA4 isotypes, the expression of PMCA2 and PMCA3 in tubules has been shown to be depressed in hypercalciuric rats (induced by feeding with a lowphosphate diet) compared to hypocalciuric rats. In brain and liver, however, PMCA2 and PMCA3 were unchanged, suggesting a specific role for these isoforms in tubular Ca 2+ reabsorption (170) .
Familial benign hypercalcemia (FBH) has been associated with defects in parathyroid-gland regulation, intrinsic renal hyperreabsorption of Ca 2+ , and global defects in cellular Ca 2+ -ATPase activities. The latter hypothesis was tested by measuring Ca 2+ -transport activity in erythrocytes and its correlation with serum calcium and serum parathyroid hormone levels in patients with FBH or primary hyperparathyroidism. The results have shown that some other mechanism than a global defect in Ca 2+ -ATPase activity is responsible for the hypercalcemia in patients with FBH (171).
A significantly increased level of kidney calcium in parallel with an elevated level of Ca 2+ -ATPase activity has been observed in kidney basolateral membranes in rats after 2 to 7 days of high-saline ingestion. This activity was not directly affected by NaCl, parathyroid hormone or calcitonin. On the other hand, the expression of mRNA for the Ca 2+ -binding protein regucalcin was markedly suppressed, suggesting that saline ingestion causes the disturbance of the Ca 2+ transport system in the kidney cortex of rats, and that the renal disorder may induce hypercalcemia (172) .
Hypercalciuria, hypomagnesia and bone mineral loss due to altered divalent cation homeostasis have been associated with human diabetes mellitus. As shown in a diabetic model, rats made diabetic by chronic (2 weeks) steptozotocin administration did not present any changes in the levels of plasma membrane Ca 2+ pump in whole kidney. Thus, the findings support the notion that PMCA pump in kidneys plays only a marginal role in the altered divalent cation homeostasis in diabetes (173) .
Proteinuria is a disorder correlated with interstitial inflammation and fibrosis, hypertension and with progression to end-stage renal disease. In response to excessive protein levels, the tubular epithelium releases factor(s) which correlate with renal insufficiency and may contribute to some of these complications. Proteinuric urine contains a small lipidic factor that acts as a powerful specific inhibitor of the Ca 2+ pump of red blood cells. This inhibitor had little or no effect on the Na + -K + -ATPase (174) . The factor is present in the circulation since hemodialysis returns the activity to normal levels. Because the Ca 2+ pump is ubiquitous, an inhibitor secreted into the urine may affect other cells and contribute to the progress of the renal disease. When reaching the circulation it may exert systemic effects on target cell Ca 2+ homeostasis like smooth-muscle cells and cause hypertension.
Circulating inhibitors of the plasma membrane Ca 2+ pump have been identified also in chronic renal failure. Chromatography and mass spectrometry of ultrafiltrate identified three factors all of which were sufficiently lipophilic to penetrate the blood-brain barrier and to accumulate in cerebral tissue (175) . All factors were additive in their inhibitory effect on PMCA activity with a non-competitive mechanism of action. These inhibitors may play a role in the pathophysiology of cellular Ca 2+ metabolism in renal failure. In very recent work Jankowski et al. (176) have characterized an inhibitor as p-hydroxy-hippuric acid. Erythrocyte Ca 2+ -ATPase has been shown to be inhibited by this compound at a concentration above 11.7 µmol/L by reducing the V max and increasing the K m value.
Adenosine, a potent autacoid produced and released in the kidney, affects nearly all aspects of renal function. In addition, an increase in [Ca 2+ ] i has been implicated in adenosine effects. Adenosine exerts a biphasic influence on the Ca 2+ -ATPase activity of basolateral membranes of kidney proximal tubules. Inhibition occurs at up to 0.1 µM and then gradually disappears. The effect is mediated by both A1 (inhibitory) and A2 (stimulatory) receptors. By using toxins, it was shown that a G-protein mediated pathway is involved that also encompasses a phospholipase C and a protein kinase C (177).
In uremic patients, the Ca 2+ content in erythrocytes is elevated. Shalev (178) 2+ ] i has been detected, the question has been addressed whether this is caused by an increased Ca 2+ influx or a decreased efflux. In the first case, any increase of PMCA expression could be the result of a compensatory mechanism. In the latter case, a decrease of PMCA function could be a causative factor.
The canine vascular wall contains at least two types of smooth-muscle cells: type 1 cells express muscle-specific proteins and do not proliferate in culture, type 2 cells do not express muscle-specific proteins and proliferate in culture. Both cell types express PMCA1 and PMCA4b. PMCA4a is absent from type 2 cells but it is upregulated in these cells upon placement in culture. The upregulation is inhibited by phosphoinositide 3-kinase inhibitors (179) .
Both elevated Ca
2+ -pump-mediated Ca 2+ efflux and elevated PMCA1 and SERCA2 mRNA levels have been observed in cultured aortic smooth-muscle cells from spontaneously hypertensive rats compared to those from the normal Wistar strain (180, 181 ). Angiotensin II increased the level of PMCA1 and SERCA2 mRNA in both strains. This study provided evidence for altered Ca 2+ homeostasis in the spontaneously hypertensive rat model affecting Ca 2+ transport ATPases at the transcriptional and functional level. It is also consistent with the hypothesis on the connected expression of these two Ca 2+ pumps (182).
In spontaneously hypertensive rats and hereditary cardiomyopathic hamsters, activities of both plasma membrane Ca 2+ -ATPase and Na + -K + -ATPase in crude myocardial homogenates have been shown to be depressed to 50 and 26 percent respectively, compared to age-matched healthy animals (183). The decrease was selective in relation to overall protein content. Reduced Na + -K + -ATPase and Ca 2+ -ATPase activities may thus be important for the development of heart failure and arrhythmia in hypertrophic heart disease. In a recent study with human subjects, however, mRNAs for both the α2 and α3 subunits of Na + pump as well as for PMCA isoforms were significantly increased in the right atrium of hypertensives compared to control subjects. This suggests a compensatory mechanism to overcome defective ion metabolism in hypertensives (184).
A dysregulated Ca 2+ homeostasis in other tissues than smooth or cardiac muscle, could point to a general causative defect contributing to the pathogenesis of hypertension. Such studies have mainly been conducted on red blood cells. Work on human hypertensive subjects yielded controversial results, with either a decreased or unaltered Ca 2+ -ATPase activity and/or Ca 2+ -pump protein density (180, 185 -188) .
The consequences of other pathologies may add up with hypertension in affecting plasmalemmal Ca 2+ -ATPase activity. Diabetes mellitus type 1 in combination with hypertension has been shown to further reduce Ca 2+ -ATPase activity. This effect was more pronounced in women than in men (133) . Interestingly, treatment of hypertension by angiotensin converting enzyme inhibitors causes a long-term enhancement of the pump activity of erythrocytes (189).
In children of essential-hypertensive patients, erythrocyte [Ca 2+ ] i is elevated. These children also showed decreased erythrocyte Ca 2+ -ATPase activities, suggesting that decreased PMCA function may be one of the mechanisms (190). Parental hypertension was also shown to be a predictor of reduced erythrocyte Ca 2+ -ATPase activity (133) .
Studies on synaptosomes revealed reduced Ca 2+ -transport activity mediated by PMCA in spontaneously hypertensive rats (191). In addition, requirements for several volatile anesthetics were also markedly reduced in these hypertensive animals.
A positive correlation has been found in hypertensive black South-Africans between hypertension and the intracellular Ca 2+ in erythrocytes and platelets, and a negative correlation with the Mg 2+ and K + concentration in plasma. In line with these findings, it has been demonstrated that platelet and erythrocytic Na + -K + -ATPase and Ca 2+ -ATPase activities were significantly depressed, which probably reflects a membrane abnormality in hypertensives (192) .
By studying the expression of SERCA and PMCA isoforms in platelets from hypertensive rats, Martin et al. (193) have shown that hypertension modulates the expression of mRNA of PMCA and SERCA in an opposite direction. Hypertension induces a decrease of PMCA1b expression and an increase of PMCA4b mRNA. Concomitantly SERCA3b/3c is downregulated and SERCA3a increases in this pathology. Hence, PMCA and SERCA proteins should be regarded as constituting a new rational basis for the understanding of non-muscle cell Ca 2+ signaling especially in platelets in hypertension.
Hypertension is a risk factor for thrombotic events. The early reports have shown that human megakaryoblastic cells (platelet precursor cells) and mature platelets express PMCA1, PMCA2 and PMCA4 isoforms (194). However, using more specific antibodies, it has been recognized that platelet precursor cells express also isoform hPMCA1b which is of smaller size than that seen in HeLa and COS-7 cells, indicating the presence of a modified form of hPMCA1b. In mature platelets, no evidence of the expression of hPMCA1b could be found. In general, the amount of all PMCA forms in precursor cells decreases dramatically during maturation and is lower than SERCA2b or the amount of PMCA in human erythrocytes (195 in hypertension. Interestingly, it was recently shown that platelet PMCA can be phosphorylated on tyrosine residues thereby inhibiting the activity. Tyrosine phosphorylation was increased in hypertensive humans, suggesting a causal link with increased platelet [Ca 2+ ] i , hyperactive platelets and increased risk of stroke (196) .
Pregnancy produces profound modifications of the platelet plasma membrane, one of which is an enhanced PMCA Ca 2+ -ATPase activity. Hypertension induced by pregnancy (PIH) further enhances PMCA Ca 2+ -ATPase activity of maternal platelets. In addition, PIH increases membrane fluidity due to alteration of the ratio between unsaturated and saturated fatty acids (197) .
One of the polymorphism's of the PMCA1 gene in humans has been investigated for a possible correlation with essential hypertension. T to G transversion has been identified resulting in the substitution of a methionine by an arginine at aminoacid position 267 in a highly conserved domain of the pump molecule. Neither this mutation nor differences in single-strand conformation polymorphism (SSCP) or in heteroduplex (HTX) analysis could be identified between hypertensives and normotensives groups (198, 199) .
This survey has shown that PMCA levels are altered in hypertension. A decrease was consistently observed in erythrocytes, and in most studies also in platelets. However, PMCA levels were increased in cultured smooth-muscle cells of the vascular wall and in cardiac atrium. Because smooth-muscle cells are intimately involved in the regulation of blood pressure, the work on cultured cells needs to be supplemented with experiments on freshly isolated tissue samples.
Disturbances in vitamin D dependent PMCA modulation
In the intestine, transcellular transport of calcium probably involves three steps: i) passive Ca 2+ entry into the enterocyte ii) translocation of Ca 2+ through its cytosol, probably bound to the Ca 2+ -binding protein calbindin iii) active extrusion of Ca 2+ across the basolateral membrane by an active transport process driven by ATP (mediated by PMCA pumps). Human and rat intestinal mucosal cells contain predominantly the PMCA1b isoform. Reflecting the capacity of the different small-intestinal segments to transport Ca 2+ , much higher levels of transcript were detected proximally (in duodenum) than distally (in jejunum and ileum). Levels were also higher in caecum and ascending colon mucosa than in descending colon (200) . These data confirm the importance of the transcriptional regulation of PMCA genes (201) .
The vitamin D dependency of the overall absorption of Ca 2+ is well documented. In addition to vitamin D status, the capacity of Ca 2+ absorption is influenced by dietary intake of Ca 2+ and phosphorus. Vitamin D replenishment is linked with significant increase of PMCA pumps and calbindin D 28K , a vitamin D dependent Ca 2+ -binding protein, in mucosal cell by a factor of 2-3. Likewise, it seems that dietary variables that enhance Ca 2+ absorption also increase the amount of PMCA pump protein (202, 203) .
Ca
2+ absorption declines with age. This is due to decreased expression of the plasma membrane Ca 2+ pump mRNA and protein, along with calbindin mRNA and protein, and the declining response of Ca 2+ absorption to vitamin D 3 with age (204) . In rats, the decline is substantial and amounts to a decrease by 90 percent in the duodenum and 65 percent in the ileum between 2 and 12 month of age. In addition, the capacity of vitamin D to increase PMCA pump protein is decreased by 61 percent in the adult compared to young animals, which correlates with the decreased capacity of vitamin D to stimulate Ca 2+ transport in adults. The expression level of Ca 2+ influx channel (epithelial calcium channel ECaC) of the apical membrane was found to be variable but to correlate closely with that of the PMCA pump. This may contribute to the individual variability in calcium absorption in humans (205) . PMCA2 and PMCA4 were not different in the two strains. However, at the protein level, calbindin-D 28K protein was more abundant, and PMCA protein was decreased in hypertensives, suggesting that the decreased PMCA level in distal cells may be responsible for the hypercalciuria in hypertensive rats (207) .
In addition to vitamin D, prolactin has been proposed as calcium regulating substance during pregnancy and lactation. Prolactin directly stimulates Ca 2+ transport in duodenum of female rats. Because the effect is inhibited by a calmodulin antagonist at the serosal side, PMCA activity could be involved in the effect (208) .
PMCA modulation in other calcium transporting tissues
The influx of large quantities of calcium and phosphate in the enamel and dentin matrices of developing teeth suggests that the formative cells may have a regulatory role in the mineralization processes. Ameloblasts which border the enamel-forming surface undergo complex changes during the secretion and enamel maturation stages in which enamel acquires the bulk of its mineral content. While the enamel forming cells supply calcium, they must avoid the cytotoxic effects of excess Ca 2+ . Disrupted Ca 2+ transport could contribute to a variety of developmental defects in enamel. The molecular machinery is a potential target for drugs to improve enamel quality (209) . The presence of PMCA has been cytochemically demonstrated in both secreting and maturating ameloblasts. An immunological study of (210) suggests a close correlation between the progression of mineralization of enamel and dentin and the amount of epitopes of PMCA pump protein. In addition to regulation of intracellular Ca 2+ , PMCA may thus play a role in the regulation of the delivery of Ca 2+ to the mineralizing enamel and dentin.
Chronic adult periodontitis is known to produce cytokines in response to changing levels of bacterial lipopolysaccharide (LPS). In gingival fibroblasts, changes in PMCA content alter several Ca 2+ -dependent activities, including the production and release of cytokines. Fibroblasts from chronic adult periodontitis patients exhibited significantly lower levels of Ca 2+ -pump protein than fibroblasts from healthy subjects. However, bacterial LPS alone did not affect significantly the amount of PMCA protein. This suggest that molecular factors other than LPS may be involved in the specific down-regulation of the Ca 2+ pump in periodontitis (211) .
Also in bone-forming cells several PMCA isoforms are expressed (212 -214) .
During lactation, the mammary gland transports large amount of Ca 2+ from the blood to milk via alveolar cells. The Ca 2+ content of most extramammary tissue increases more than 12 fold at the time of initiation of lactation. The control of [Ca 2+ ] i essential to normal cell function requires the concerted effort of several Ca 2+ -ATPases. Three mRNAs for plasma membrane Ca 2+ -ATPases (PMCA1b, PMCA2b and PMCA4b) and two mRNAs for SERCAs (SERCA2 and SERCA3) and the rat homologue to the yeast Golgi Ca 2+ -ATPase have been identified by RT-PCR analysis. Generally, transcripts increased from the 7th day of pregnancy to the 14th day of lactation. The PMCA2b is the most abundant transcript and at the peak of lactation its levels approached that of actin. The presence of PMCA2b in lactating glands is of particular interest, since this isoform was observed in significant amount only in brain and nervous tissue. The very high affinity of PMCA2 for Ca 2+ and calmodulin indicates that like in brain, PMCA-mediated Ca 2+ extrusion is extremely effective also in mammary glands (215) .
Similarly to kidney and intestine, PMCA immunolabeling is conspicuous in basal (fetal facing) layers of placental syncytiotrophoblasts, a site of translocation of large amounts of Ca 2+ (216) . The ratio of calbindin 9K mRNA level to beta actin mRNA increased 135 fold during gestation in rats and was associated with materno-fetal clearance of calcium (217) . However, the ratio of PMCA to actin rose only two to three times. Thus, its seems that expression of the calbindin 9K but not PMCA is rate-limiting for placental Ca 2+ transport in the rat. During gestation in humans, however, PMCA levels did not change. There was however a clear activation of Ca 2+ transport in isolated basal membrane vesicles (218) . Placental trophoblasts from preeclamptic women express a 50 percent lower Ca 2+ -ATPase activity compared to normotensive pregnant women (219) . The pathophysiological meaning of this observation is, however, not clear.
PMCA protein is also present in mammalian eye tissue. As documented by immunofluorescent study, in the normal corneal epithelium, both plasmalemmal Ca 2+ -pump and caveolin are located along the cell surface. In the regenerating epithelium after injury, plasmalemmal Ca 2+ -pump stains as many dots in the cytoplasm around the plasma membrane. In contrast, caveolin persisted along the cell surface and remained in caveolae. When the wound closes, the Ca 2+ pump regains its normal distribution. This indicates that caveolae undergo compositional modification during the healing process and that the phenomenon may be related to possible fluctuations of [Ca 2+ ] i in the regenerating epithelium (220). -ATPase inhibition as probed by SH compounds like glutathione which reverse the inhibition suggests a direct oxidation of protein sulhydryls, not a secondary process involving oxidation-induced lipid structural changes or products of lipid oxidation (222) . Binding of lens alpha cristallin in vitro to the membrane lipids did not protect the Ca 2+ ATPase from thermal or oxidative damage (223) .
The blood-brain barrier and blood-cerebrospinal fluid (CSF) barrier are involved in the long-term regulation of the concentration of Ca 2+ and K + in the whole brain and CSF. The plasma membrane Ca 2+ pump is located on the apical membrane of the choroid plexus (CSF facing) membrane (224) . Only a limited number of papers deal with the role of PMCA in the choroid plexus in pathological states. The importance of PMCA at the blood-CSF and blood-brain barrier has been examined in brain Ca 2+ homeostasis in dietary acquired hypo-and hypercalcinemia (225) . Western blot analysis revealed that the amount of PMCA protein in the choroid plexus did not vary with the plasma Ca 2+ concentration. In contrast, in cerebral microvessels from hypocalcemic rats a 150 percent increase of PMCA molecules was found. The location of the PMCA at the blood brain barrier has not been firmly established although there is evidence for an abluminal (brain facing) Ca 2+ -ATPase distribution (226) , which could suggest that the increase in the amount of PMCA in the microvessels in hypocalcemia would contribute to maintain Ca 2+ flux from blood to brain.
ALTERATIONS OF PMCA IN AGING
Biological aging is a fundamental process that results in a progressive decline in cellular function. There is a possible linkage between the energetic costs associated mainly with the maintenance of the intracellular Ca 2+ gradient necessary for cellular signaling, oxidative damage and the loss of physiological responses associated with aging. Thus, oxidative stress, and the loss of Ca 2+ -regulation are implicated as primary factors associated with degeneration including aging (61). The cellular alterations with progressing age involve mechanisms which are still unresolved.
Effect of aging on PMCA in neuronal cells
In a series of papers Michaelis´s group has described that as a function of aging both the activity and membrane levels of the brain PMCA Ca 2+ -ATPase are significantly reduced in both Fischer 344 and the longer lived Fischer 344/Brown Norway hybrid rats (227, 228) . In addition, PMCA pump activity from 34 month old animals showed a decrease of V max from 60.9 to 32.4 nmol/mg/min with no change in affinity for Ca 2+ partly due to a decreased level of calmodulin and its ability to stimulate PMCA activity in old animals (229) .
The PMCA pump is very sensitive to inhibition by RO(N)S in vitro and hence may be a target of oxidative stress in the aging brain. In addition, the loss of PMCA immunoreactivity after exposure to ONOO -suggests that this radical induces fragmentation of the PMCA protein (47). Since the increase in hydrophobic interactions, carbonyl groups and nitrotyrosine formation have been reported for various proteins in aged tissues, it is possible that increased oxidative stress in the aging brain can also lead to modifications of PMCA proteins. Similarly to the effect of in vitro oxidative stress (47), a decrease of the Ca 2+ -ATPase activity has been observed in aged rats (230) . Calcium content in brain tissue was also significantly raised in aged rats (50 weeks) as compared to young animals (5 weeks). As shown by using SH-group modifying factors there were no differences in extent of Ca 2+ -ATPase activity inhibition between aged and young groups, suggesting that SH groups in active sites of the enzyme are probably not impaired in aging. Interestingly, also the ability of the Ca 2+ -ATPase to respond to signaling factors such as cAMP and calmodulin, decreased or disappeared. The findings at least partially explain aging-induced mechanisms causing calcium accumulation in brain (230) .
As reviewed recently, post-translational structural changes of critical Ca 2+ -regulatory proteins such as calmodulin have been identified which result in the inability to activate a range of target proteins, including the PMCA pump (61). Oxidation of multiple methionines to corresponding methionine sulfoxides within calmodulin during aging leads to a nonproductive and conformationally disordered complex with PMCA protein. In contrast to the results with calmodulin obtained from senescent Fischer 344 rats, calmodulin isolated from the long-lived Fischer 344/BNF1 is not oxidatively modified in animals that are 34 months old. In addition, in Fischer 344 rat brain there is a large decrease in the function of the 20S proteasome, which in vitro selectively degrades oxidized calmodulin. Thus, these findings indicate that structural and functional changes of calmodulin and PMCA protein are consistent with the observed decreases in Ca 2+ regulation in senescent animals (61, 231).
In the hippocampus of senescence-accelerated P8 mice, the levels of protein kinase C gamma and of calbindin decline markedly with age. However, the level of total PMCA molecules did not change significantly with age (232) . Because in this study antibodies were used which recognized all PMCA isoforms, the possibility that individual isoforms do change with age is not excluded. Our unpublished data also indicate possible conformational alterations of the protein molecules or age-related protein modifications of the ion-transport ATPases which may contribute to age-induced changes in hippocampal function.
Effect of aging on PMCA in other cell types
A general response to aging in myocardial cells is a prolonged excitation-contraction coupling cycle. At the transcriptional level, the density of the SERCA Ca 2+ pump was reduced as a consequence of the downregulation of the gene (233) . Only one paper deals with the effect of aging on PMCA in myocardial cells. Frolkis et al. (234) in a study of myocardial hypertrophy induced by aorta coarctation proposed a role of molecular intracellular regulators which increase the activities of the Na + -K + -pump or the plasmalemmal Ca 2+ pump. They showed in adult rats (6 -8 months) that coarctation induces an increase of Na + -K + -ATPase and Ca 2+ -ATPase activities, whereas in old rats only the Ca 2+ -ATPase is affected. Because the effects can be mimicked by addition of isolated cytosol to control membranes, the authors propose that aorta coarctation induces the synthesis of activators in adult rats. Because cytosol of old animals after coarctation did not activate the Na + -K + -ATPase, but was shown to activate the Ca 2+ -ATPase, the authors suggested the occurrence of two different regulators.
CONCLUSIONS AND PERSPECTIVES
Ca
2+ homeostasis is crucial for cell function and survival. Local Ca 2+ signalling requires systems for both the entry and the removal of Ca 2+ maintained under precise spatial and temporal control. Mechanisms that regulate cellular Ca 2+ have been studied extensively, and remarkable progress has been made in understanding their roles also in pathological conditions. Although the general function of PMCA is well documented, much less is known about the role of specific PMCA isoforms, their spatial organization and especially their contribution to the onset and progress of pathological conditions.
Up till now no human disease has been linked to a defect in any of the PMCA genes, which could be indicative of a high degree of redundancy of the functions of each isoform. However, molecular biology techniques have given striking examples of the indispensability of specific gene products for several physiological functions. The PMCA2 isoform in the ear is a striking example.
Alterations of PMCA isoform expression at the transcriptional level have been described in response to The regulation of PMCA expression by vitamin D in transporting epithelia is generally observed. PMCA expression and the response to vitamin D decline with age. In addition, the expression and functional state of PMCA protein is influenced by other pathogenic factors such as mineral dysregulation.
Depressed Ca 2+ -ATPase activity in aging may not only occur at the level of the PMCA protein itself, but may also be caused by structural oxidative changes of critical regulatory proteins such as calmodulin.
Investigation of pathology-induced changes in the level and activity of PMCA Ca 2+ pumps may help to identify patterns that are specific for vulnerable and resistant cells. Knowledge of such a pattern would greatly assist the development of specific therapeutic strategies to activate recovery of Ca 2+ extrusion and help to establish whether these changes are of relevance to the pathological process leading to cell injury.
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